Cimetidine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.04.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

H2 antagonist.

IndicationThis section has been translated automatically.

Gastrointestinal ulcers, reflux esophagitis, recurrent ulcers after surgery, Zollinger-Ellison syndrome. Recurrence prophylaxis of duodenal ulcers, anastomotic ulcers. Therapy and recurrence prophylaxis of drug-induced lesions in the upper gastrointestinal tract, prophylaxis of drug-induced lesions in patients with ulcer history.

Dosage and method of useThis section has been translated automatically.

  • Acute treatment of gastrointestinal ulcers, reflux esophagitis, drug-related lesions, recurrent ulcers after surgery: 800 mg cimetidine per day.
  • Prevention of recurrence of duodenal ulcers, anastomotic ulcers: 400 mg cimetidine per day. Recurrence prophylaxis of drug-related lesions: 400-800 mg cimetidine per day.
  • Prophylaxis of drug-induced lesions in patients with history of ulcers: 800 mg cimetidine per day. Zollinger-Ellison syndrome: 1.0-2.0 g cimetidine per day.

ContraindicationThis section has been translated automatically.

Stomach cancer. Cave! Children and adolescents in growing age. Note: Dose adjustment for impaired kidney function!

PreparationsThis section has been translated automatically.

Tagamet®, Cimetidine, Cime-Hexal®

Authors

Last updated on: 29.04.2021

Author: Prof. Dr. med. Peter Altmeyer